Literature DB >> 2331520

Point mutations in the uroporphyrinogen III synthase gene in congenital erythropoietic porphyria (Günther's disease).

J C Deybach1, H de Verneuil, S Boulechfar, B Grandchamp, Y Nordmann.   

Abstract

Congenital erythropoietic porphyria (Günther's disease) is a rare disorder of heme biosynthesis inherited in an autosomal recessive fashion. The molecular abnormality responsible for the characteristic defect in uroporphyrinogen III synthase activity was investigated in two patients. For the first patient, complementary DNA was specifically amplified using the polymerase chain reaction and subsequently cloned and sequenced. Data obtained revealed the coexistence of two distinct point mutations: a T to C change in codon 73 (arginine in place of a cysteine) and a C to T change in codon 53 (leucine in place of a proline). The second case was studied by hybridization with allele specific oligonucleotides and was found to be homozygous for the same mutation in codon 53. These are the first mutations to be recognized in the uroporphyrinogen III synthase gene from congenital erythropoietic porphyria patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2331520

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

1.  A novel point mutation in congenital erythropoietic porphyria in two members of Japanese family.

Authors:  K Tanigawa; M Bensidhoum; N Takamura; H Namba; S Yamashita; H de Verneuil; C Ged
Journal:  Hum Genet       Date:  1996-05       Impact factor: 4.132

2.  The molecular defect of ferrochelatase in a patient with erythropoietic protoporphyria.

Authors:  Y Nakahashi; H Fujita; S Taketani; N Ishida; A Kappas; S Sassa
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

3.  Gene transfer of the uroporphyrinogen III synthase cDNA into haematopoietic progenitor cells in view of a future gene therapy in congenital erythropoietic porphyria.

Authors:  F Mazurier; F Moreau-Gaudry; S Salesse; C Barbot; C Ged; J Reiffers; H de Verneuil
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

4.  The cDNA sequence of mouse uroporphyrinogen III synthase and assignment to mouse chromosome 7.

Authors:  M Bensidhoum; C M Ged; C Poirier; J L Guénet; H de Verneuil
Journal:  Mamm Genome       Date:  1994-11       Impact factor: 2.957

Review 5.  Porphyrias: animal models and prospects for cellular and gene therapy.

Authors:  H de Verneuil; C Ged; S Boulechfar; F Moreau-Gaudry
Journal:  J Bioenerg Biomembr       Date:  1995-04       Impact factor: 2.945

6.  Ocular involvement in two symptomatic congenital erythropoietic porphyria.

Authors:  F Oguz; M Sidal; C Bayram; N Sansoy; N Hekim
Journal:  Eur J Pediatr       Date:  1993-08       Impact factor: 3.183

7.  Effective gene therapy of mice with congenital erythropoietic porphyria is facilitated by a survival advantage of corrected erythroid cells.

Authors:  Elodie Robert-Richard; François Moreau-Gaudry; Magalie Lalanne; Isabelle Lamrissi-Garcia; Muriel Cario-André; Véronique Guyonnet-Dupérat; Laurence Taine; Cécile Ged; Hubert de Verneuil
Journal:  Am J Hum Genet       Date:  2008-01       Impact factor: 11.025

8.  Heterogeneity of mutations in the uroporphyrinogen III synthase gene in congenital erythropoietic porphyria.

Authors:  S Boulechfar; V Da Silva; J C Deybach; Y Nordmann; B Grandchamp; H de Verneuil
Journal:  Hum Genet       Date:  1992-01       Impact factor: 4.132

9.  Congenital erythropoietic porphyria: identification and expression of exonic mutations in the uroporphyrinogen III synthase gene.

Authors:  C A Warner; H W Yoo; A G Roberts; R J Desnick
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

10.  A Case of Congenital Erythropoietic Porphyria without Hemolysis.

Authors:  Arun K De; Kallol Das; Archan Sil; Swarnali Joardar
Journal:  Indian J Dermatol       Date:  2013-09       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.